Moncef Slaoui — MDRPedia
MS
Top 1% — Elite

Moncef Slaoui

Immunology · Vaccine Development

Philadelphia, Morocco

50 H-Index
3,143 Citations
409 Total Impact
PEGalien Foundation Prix Galien Award0

Overview

Moncef Slaoui is an immunology specialist who led Operation Warp Speed for COVID-19 vaccine development. Oversaw 14 new vaccines at GSK over 30 years. Based in Philadelphia, United States.

For Patients

  • Research is cited 3K+ times by other doctors and scientists
  • Currently at Operation Warp Speed (US Government) in Philadelphia, Morocco

Biography

Moncef Slaoui is a Moroccan-Belgian-American immunologist who served as chief scientific advisor for Operation Warp Speed, the US government program that developed COVID-19 vaccines in record time. Previously he led vaccine development at GlaxoSmithKline for 30 years, overseeing 14 new vaccines including those for cervical cancer and malaria.

Affiliations & Institutions

Research Impact

10 Publications
3,143 Total Citations
1K+ Citation Milestone

Publication Timeline

01219861996199820022020

Published In

New England Journal of MedicineThe Journal of Infectious DiseasesProceedings of the National Academy of SciencesVaccineInfection and Immunity

Areas of Expertise

Legacy Timeline

The life and contributions of Moncef Slaoui

1988

Joined GlaxoSmithKline

Began 30-year career in vaccine development at GSK

2007

Chairman of Global Vaccines at GSK

Led development of 14 new vaccines including Cervarix (HPV) and Mosquirix (malaria)

2020

Chief Scientific Advisor of Operation Warp Speed

Led the US government program that developed COVID-19 vaccines in under a year

Related Specialists

View All